Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BMY
BMY logo

BMY News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

BMY News

China's Pharma Sector Unaffected by Regulatory Scrutiny

4d agoNewsfilter

Bristol Myers Squibb Shares Rebound but Risks Remain

6d agoFool

Bristol Myers Squibb Faces Daunting Patent Cliff

6d agoNASDAQ.COM

BMY Shares Snap Six-Day Gain with Minor Decline

May 22 2026seekingalpha

Bristol Myers Squibb Showcases New Drug Research Results

May 21 2026Newsfilter

Bristol Myers Squibb's Stock Lacks Confidence Despite Strong Fundamentals

May 21 2026Fool

Bristol Myers Squibb Valuation Low but Growth Prospects Positive

May 21 2026NASDAQ.COM

BioArctic AB Reports Strong Earnings, Positive Outlook for Leqembi Sales

May 20 2026Yahoo Finance

BMY Events

05/20 07:00
Bristol Myers Squibb Signs Strategic Agreement with Anthropic
Bristol Myers Squibb announced a strategic agreement with Anthropic to deploy Claude across the company's research, clinical development, manufacturing, commercial, and corporate functions. The collaboration signals a meaningful evolution in how BMS deploys AI, moving beyond conversational tools that have defined the first wave of enterprise adoption, toward agentic capabilities built into the day-to-day workflows and systems that underpin its science and global operations. BMS will deploy Claude broadly across the company, empowering more than 30,000 employees with advanced reasoning and agentic capabilities.
05/18 16:20
Stocks Open Mixed as Rising Oil Prices Raise Concerns
Stocks finished mixed to start the week as investors continue to watch climbing oil prices while awaiting more developments out of the Middle East. Investors are increasingly worried that inflation is becoming entrenched due to energy prices, persistent fiscal deficits and resilient economic demand. Markets are now pricing in a meaningful possibility that the Federal Reserve could raise rates again later this year instead of cutting them.Of note, President Trump stated in athat he was asked by the leaders of several Middle Eastern nations to hold off a planned military attack on Iran, which was scheduled for tomorrow, but added that he has instructed the U.S. military leadership "to be prepared to go forward with a full, large scale assault of Iran, on a moment's notice, in the event that an acceptable Deal is not reached."Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Dominionand NextEra Energyin an all-stock transactionPublicisLiveRampfor $2.2BFordand EDF Group announced the signing of aTrump plans to announce a "dramatic expansion" of discounted prescription medication offerings available on TrumpRx,A U.S. jury on Monday ruled against Elon Musk in his lawsuit against OpenAI, finding the AI company not liable to the Teslafounder for having allegedly strayed from its original mission to benefit humanity,2. WALL STREET CALLS:F5to Outperform from In Line at Evercore ISIZscalerto Buy at B. RileyCoreWeaveand Nebiuswith lowered Neutral ratings as a new analyst took over coverage at DA DavidsonApplied Materialsto Equal Weight at Morgan StanleySalesforcewith an Underperform at BofA amid structural reset3. AROUND THE WEB:NvidiaCEO Jensen Huang told Bloomberg that it is up to China to decide on AI chips and that he looks forward to China being a more open marketTakedahas been ordered to pay hundreds of millions for violating antitrust law by delaying the generic version of its branded Amitiza drug, Bloomberg saysApple'srevamped Siri may launch in beta, and will have an option to auto-delete chats, Bloomberg reportsPresident Trump said he "should have asked for more" of a stake in Intelon behalf of the U.S. government, Fortune saysVinFast'splanned sale of two Vietnamese factories will allow the company to shed $6.9B in debt and obligations to help assist its path to profitability, Bloomberg says4. MOVERS:Hive Digitalwas higher afteris planning to build a new AI infrastructure facility in the Greater Toronto Area with approximately 320 megawatts of utility capacityCourseraincreased after announcing aServiceNowgained after BofAcoverage of the stock with a Buy ratingDesign Therapeuticswas lower afterRegeneronfell after its Phase 3 trial of fianlimab5. EARNINGS/GUIDANCE:Bradyand raised its guidance for FY26iQiyi, with EPS and revenue lower year-over-yearGossamer Bio, with CEO Faheem Hasnain commenting, "We are executing across multiple fronts at Gossamer"RedCloudreportedand reaffirmed guidance for FY26Baidu, with EPS and revenue lower year-over-yearINDEXES:The Dow rose 159.95, or 0.32%, to 49,686.12, the Nasdaq lost 134.41, or 0.51%, to 26,090.73, and the S&P 500 declined 5.45, or 0.074%, to 7,403.05.
05/18 11:40
Trump to Announce Expansion of TrumpRx Discounted Prescription Medications
U.S. President Donald Trump is slated to announce this afternoon a "dramatic expansion" of discounted prescription medication offerings available on TrumpRx, CNBC's Megan Cassella reports, citing a White House official. Trump is set to speak at a healthcare affordability event at 4:30 pm ET Monday, the author notes. Publicly traded companies in the space include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).

BMY Monitor News

Bristol-Myers Squibb Reports Strong Q1 Earnings, Exceeds Expectations

Apr 30 2026

Bristol-Myers Squibb Reports Strong Q4 Earnings and Upgraded Outlook

Feb 06 2026

Bristol-Myers Squibb signs multi-year supply agreement with OXB

Feb 04 2026

Bristol-Myers Squibb Co reaches 20-day high amid sector rotation

Jan 07 2026

Bristol-Myers Squibb's Opdivo Receives FDA Priority Review

Dec 15 2025

Bristol-Myers Squibb's Opdivo Receives FDA Priority Review

Dec 12 2025

Bristol-Myers Squibb faces significant legal challenges

Dec 03 2025

BMY.N Hits 5-Day High Amid Investor Event Buzz

Nov 24 2025

BMY Earnings Analysis

Bristol-Myers Squibb Q1 2025 Earnings: Growth Strategy- Intellectia AI™
1 years ago
Strong Growth in Key Segments Marks Bristol Myers Squibb Q4 2024 Earnings Report - Intellectia AI™
1 years ago
Bristol Myers Squibb Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch